electro-nucleonics &lt;enuc> 2nd qtr dec 31 shr loss 1.77 dlrs profit 15 cts net loss 8,036,000 profit 576,000 sales 16.2 mln 17.2 mln avg shrs 4,539,437 3,816,580 1st half shr loss 1.96 dlrs profit 26 cts net loss 8,231,000 profit 996,000 sales 30.9 mln 32.2 mln avg shrs 4,205,707 3,814,141 note: current half net includes 68,000 dlr tax credit. current year net periods includes 6,700,000 dlr writedown inventory clinical chemistry products.